Gene Query: PRR7

Dataset Description Geneva Score
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 20.62
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 19.9
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 17.23
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 15.68
Differetially expressed genes after hTR overexpression in U2OS cells 15.66
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 14.07
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 13.69
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 13.69
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 13.42
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 12.25
CHD1 regulates cell fate determination by activation of differentiation-induced genes 11.92
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 11.03
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 11.03
Active translatome profiling with RiboLace in MCF7 cells 9.94
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 9.64
Intrahepatic MAIT cell gene expression revealed by RNA-seq 9.03
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 8.86
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 8.86
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 8.84
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 8.23
Effect of ILF3 on translation during homeostasis and the antiviral response 8.0
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 7.89
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 7.59
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 7.58
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 7.51
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 7.24
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 7.19
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 7.14
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 7.14
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 7.05
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 6.79
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 5.81
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 5.81
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 5.81
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 5.49
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 5.44
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 5.42
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 5.42
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 5.31
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.31
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 5.12
Identification of global regulators of T-helper cell lineage specification 4.92
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 4.92
Glioblastoma stem cells infected by ZIKA virus 4.9
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 4.9
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 4.9
Global epigenomic reconfiguration during mammalian brain development 4.84
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 4.79
Generating Patterned Kidney Organoids for Studying Development and Diseases 4.75
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 4.73
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.72
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.72
Altering cancer transcriptomes using epigenomic inhibitors 4.72
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 4.72
Next Generation Sequencing of human SMA and healthy control Motor Neurons 4.59
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 4.52
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.52
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 4.3
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 4.28
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.27
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 4.21
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 4.17
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 4.07
Chromatin landscape of human visceral and subcutaneous adipocytes 3.89
Regulation of highly expressed hCINAP on translatome 3.84
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.84
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.84
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.8
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.79
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.75
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.71
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 3.65
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 3.65
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 3.62
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 3.61
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 3.49
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 3.42
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 3.4
A single cell reference map for human blood and tissue T cell activation 3.39
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 3.38
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 3.32
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 3.32
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.31
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.31
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 3.28
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 3.28
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.23
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.23
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.16
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 3.13
Differential gene expression of human melanoma cells [RNA-seq] 3.12
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 3.12
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 3.03
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.02
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.99
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.96
RNA polymerase in pre-B-ALL cell lines 2.88
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.84
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.84
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.72
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.72
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 2.7
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.7
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 2.61
The evolution of N6-methyladenosine in primates 2.6
snRNAs as regulators of alternative splicing 2.6
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.6
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 2.59
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 2.59
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 2.57
RNA-seq of tumor cells following angiopellosis extravasation 2.54
NR2F2 study 2.53
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.53
Small-molecule targeting of brachyury transcription factor addiction in chordoma 2.52
AUF-1 affected genes in human skin cells 2.51
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 2.48
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.47
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 2.41
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 2.4
Paxillin regulates genomic networks in prostate cancer [C4-2] 2.38
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 2.34
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 2.33
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 2.32
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.31
Gene expression changes in human melanoma cell lines compared to primary melanocytes 2.28
Effect of CHKA knockdown on C4-2 cell transcriptome 2.28
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 2.27
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.24
RNA-seq analysis of uveal melanoma cells treated with FR900359 2.24
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.22
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.2
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 2.2
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 2.18
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 2.18
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.18
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.17
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 2.15
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 2.12
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.1
Dysregulated immune system networks in war veterans with PTSD 2.1
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.09
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 2.09
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.05
RNAseq analysis of ESRP regulated splicing events in prostate cancer 2.05
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.05
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 2.04
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 2.01
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 2.01
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.99
High-Throughput Kinetic Analysis of Fractional Killing 1.97
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.91
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 1.89
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.88
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.87
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 1.87
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.86
Silencing SPIB in attached and floating state of H1703 lung cancer cells 1.84
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 1.82
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.82
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.81
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 1.79
RNAseq of HEK293 cells after Chtop knockdown 1.78
Co-transcriptional loading of RNA export factors shapes the human transcriptome 1.78
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 1.77
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 1.77
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.76
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 1.71
Genome wide expression change by RNF168 knocking down in MCF-7 cells 1.71
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.7
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 1.7
Ro60-knockout cells 1.7
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 1.7
RNAseq of cell lines with knocked in ESR1 mutations 1.69
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 1.69
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 1.69
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.63
Gene expression analysis of breast cancer cell-lines 1.63
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 1.61
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.58
m6A-dependent regulation of messenger RNA stability 1.57
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.56
Comparing gene expression in iPSC derived RPE from control and AMD donors 1.55
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 1.54
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 1.53
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 1.53
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.53
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 1.53
MAIT cell RNA sequencing 1.53
Transcriptome of U251 cells overexpression complement component 7 1.52
METTL3 promotes translation in human cancer cells 1.5
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 1.5
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.49
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.48
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 1.48
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 1.47
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.46
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.46
Genome wide expression change in LCC2 and MCF-7 cells 1.45
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.44
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 1.43
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 1.42
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 1.4
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 1.4
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 1.39
RNA sequencing of human pancreatic cancer cell lines 1.39
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.39
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.38
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 1.38
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.37
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.37
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.37
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.36
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 1.35
LncRNA-GAS5 negative regulation of YAP-target genes expression 1.35
RNAseq Analysis in glioblastoma cells treated with Mepazine 1.34
The landscape of alternative splicing in aggressive prostate cancers 1.34
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 1.33
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.32
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.32
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 1.31
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 1.31
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 1.3
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.3
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 1.28
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 1.26
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.26
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 1.25
Characterization of human ILC2 subsets 1.25
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.25
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 1.25
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.24
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.23
Discovering human diabetes-risk gene function with genetics and physiological assays 1.22
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.22
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.21
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.21
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.21
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 1.2
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.19
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 1.19
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.18
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 1.16
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.14
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.14
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.13
PTHrP overexpression in MCF7 cells 1.13
The transcriptome effect of overexpressing EZH2 in MCF7 1.13
RNA-seq analysis of BAP1-depleted uveal melanoma cells 1.12
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.12
Impact of dieldrin on transcription in Jurkat T cells 1.11
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 1.11
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 1.11
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 1.11
Tpl-2 and MEK small molecule inhibitors 1.1
Tpl-2 small molecule project 1.1
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 1.1
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.09
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 1.09
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 1.09
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 1.09
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 1.08
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.07
CSL RNA-Seq on HKC and SCC cell lines 1.07
CSL 1.07
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.07
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 1.07
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 1.06
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 1.06
Identification of HOXB13 target genes responsive to BET inhibitors 1.06
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.06
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.06
Transcriptome analysis of SKI knock-out in HL60 cells 1.04
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 1.04
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 1.03
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.03
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 1.03
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 1.02
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.02
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 1.01
The MEF2B Regulatory Network - RNA-seq data 1.01
The MEF2B Regulatory Network 1.01
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.0
Gene expression in GBM with Cav3.2 inhibition 1.0
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 0.99
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.98
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.98
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 0.98
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 0.97
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 0.96
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 0.96
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.95
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.94
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 0.92
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.92
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.92
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.91
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 0.91
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.9
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 0.89
Regulatory network controlling tumor-promoting inflammation in human cancers 0.89
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 0.89
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.89
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 0.88
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 0.88
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.87
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.87
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.87
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.87
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.87
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 0.86
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 0.85
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 0.85
MCF-7 as a model for functional analysis of breast cancer risk variants 0.85
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 0.85
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 0.84
Gene expression profiling of leukemia cells following asparagine depletion 0.84
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.83
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.83
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.82
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.82
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.82
Primary Human B-cell Temporal Response to CD40L Stimulation 0.82
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 0.81
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 0.79
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.79
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 0.79
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.79
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.79
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 0.79
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.78
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.78
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.78
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 0.78
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.78
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 0.77
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.76
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.76
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 0.75
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 0.75
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 0.74
Paxillin regulates genomic networks in prostate cancer [LNCaP] 0.74
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.74
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.72
Patient-derived xenograft platform for metastatic melanoma 0.71
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 0.71
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.7
Intron retention induced by microsatellite expansions as a disease biomarker. 0.69
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.68
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 0.67
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 0.67
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 0.67
Transcriptional responses of melanoma cells to BRAF inhibition 0.67
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.66
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.66
High-throughput sequencing of pluripotent cells 0.66
Analyses of T-ALL (COG study) 0.66
RNA sequencing of T-ALL (COG study) 0.66
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 0.66
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.66
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.66
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 0.65
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.65
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.64
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.64
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.63
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.63
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.63
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.63
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.63
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.63
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.62
TFAP2C signalling in human fibroblasts 0.62
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.62
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.61
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.61
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 0.6
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 0.6
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.6
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 0.6
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.59
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.59
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.59
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.59
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.58
The role of m6A/m-RNA methylation in stress response regulation 0.58
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 0.58
An integrative analysis of non-coding regulatory DNA variations associated with autism 0.58
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.57
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.57
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 0.57
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 0.57
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.56
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.54
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.54
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 0.54
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.52
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.52
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.51
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.51
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.5
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 0.5
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.5
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.49
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.49
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 0.48
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 0.47
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 0.47
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 0.46
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.46
A prostate cancer chromatin interaction map 0.45
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.45
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.45
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.45
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 0.44
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.43
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.42
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 0.41
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.41
The role of the Calcium-Sensing receptor in colorectal cancer 0.39
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.38
Gene expression profile in breast cancer cell lines using RNA sequencing 0.37
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 0.37
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.37
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.37
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.36
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.36
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.36
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.36
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 0.35
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.35
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.35
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.35
Positively selected enhancer elements endow tumor cells with metastatic competence 0.34
Ribosome profiling upon inhibition of eIF4A 0.34
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 0.34
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 0.34
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.34
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.34
SUV420H2 knockdown in PANC-1 0.32
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.31
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.31
CDK4/6 inhibitor resistance in prostate cancer 0.3
H1609088 Human RNA-Sequencing 0.3
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.3
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.29
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.29
Identification of global XBP1s target gene expression in human prostate cancer cells 0.28
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.28
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.27
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.27
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.27
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.26
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.26
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.26
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.25
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.25
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.24
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 0.24
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.23
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.23
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.23
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.23
Single cell transcriptome of peritoneal cells 0.22
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.22
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 0.21
KLF6-dependent transcription in renal cancer cells 0.19
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.19
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.18
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.18
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.16
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.15
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.14
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.14
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.14
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.13
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.13
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.13
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.12
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.12
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.12
Copper Regulation of HIF-1 Transcription Activity 0.09
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.09
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.09
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.09
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.09
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.07
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.07
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 0.07
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.06
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.05
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 0.04
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.04
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.03
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.03
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.03
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 0.03
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 0.03
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.02
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 0.02
RNA editing in nascent RNA affects pre-mRNA splicing 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation